These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20369799)

  • 1. Selected aspects of europeization of pharmaceutical law.
    Zimmermann A; Wengler L; Pawłowski L
    Acta Pol Pharm; 2010; 67(2):205-10. PubMed ID: 20369799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marketing authorization of veterinary medicinal products in Poland.
    Sztabińska-Koncka H; Lewicki J
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical markets regulation overview of the selected European Union countries.
    Pogorzelczyk K; Synoweć J; Robakowska M; Ślęzak D; Holajn P; Robakowski P; Żuratyński P; Nadolny K
    Wiad Lek; 2018; 71(7):1404-1408. PubMed ID: 30448818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal products in the European Union--between harmonization and divergence.
    Lojko N
    Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
    Czerw A; Marek EM
    Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Harmonisation of regulatory requirements for clinical trials on medicinal products for human use in the Directive 2001/20/EC and complementary guidance. Implementation of the 12th Law Amending the German Drug Law].
    Geisler I; Hofmann HP; Nickel L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):141-6. PubMed ID: 15726454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Supervision of cosmetic products].
    Urbanek-Karłowska B; Smietanka B; Pawłowska K; Biernat U; Burzyńska I
    Rocz Panstw Zakl Hig; 2001; 52(3):257-65. PubMed ID: 11771119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legal instruments supporting the development of orphan medicinal products in the European Union.
    Miaskowska-Daszkiewicz K
    Acta Pol Pharm; 2014; 71(1):181-7. PubMed ID: 24779206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns].
    Cianciara D
    Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attempt to exclude invasive cardiology services in Poland--rationing, national sovereignty and European Union law].
    Gericke CA; Busse R; Sakowska I; Kuszewski K; Maciag A
    Przegl Epidemiol; 2006; 60(2):323-9. PubMed ID: 16964685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two steps back: Poland's new abortion law.
    Nowicka W
    Plan Parent Eur; 1993 Jun; 22(2):18-20. PubMed ID: 12287103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
    Moulin G
    Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Community requirements relating to drugs derived from human blood and plasma].
    Brunko P
    Ann Pharm Fr; 1994; 52(2):89-98. PubMed ID: 7944184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of an anticancer drug in Japan based on a new clinical trial system].
    Nakashima H; Nakano S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autopsy--legal basis (Part I)].
    Barzdo M; Berent J
    Przegl Lek; 2009; 66(5):266-8. PubMed ID: 19739586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.